Underground parts of three Valeriana species, namely V. officinalis L.
s.l., V. wallichii DC. (V. jatamansi Jones), and V. edulis Nutt. ex T
orr & Gray ssp. procera (H.B.K.) F. G. Meyer (V. mexicana DC.), are us
ed in phytotherapy because of their mild sedative properties. Characte
ristic constituents of these species, which are regarded also as the a
ctive principles, were tested for cytotoxicity against GLC(4), a human
small-cell lung cancer cell line, and against COLO 320, a human color
ectal cancer cell line, using the microculture tetrazolium (MTT) assay
. Valepotriates of the diene type (valtrate, isovaltrate and acevaltra
te) displayed the highest cytotoxicity, with IC50 values of 1-6 mu M,
following continuous incubation. The monoene type valepotriates (didro
valtrate and isovaleroxyhydroxydidrovaltrate) were 2- to 3-fold less t
oxic. Baldrinal and homobaldrinal, decomposition products of valepotri
ates, were 10- to 30-fold less toxic than their parent compounds. Isov
altral had a higher cytotoxicity than its parent compound isovaltrate.
Valerenic acids (valerenic acid, acetoxyvalerenic acid, hydroxyvalere
nic acid and methyl valerenate), which are characteristic for V. offic
inalis, had a low toxicity with IC50 values between 100 and 200 mu M.
Freshly prepared and stored tinctures, prepared from roots and rhizome
s of the three valerian species, were analysed for valepotriates, bald
rinals and valerenic acids, and also tested for cytotoxicity. There wa
s a clear relationship between the valepotriate contents of the freshl
y prepared tinctures and their toxicity. Upon storage, valepotriates d
ecomposed, which was reflected in a significant reduction of the cytot
oxic effect.